<DOC>
	<DOCNO>NCT00184743</DOCNO>
	<brief_summary>This trial conduct Japan . To investigate long-term efficacy assess change fat mass safety 48 week treatment Growth Hormone adult Growth Hormone Deficiency , compare two different treatment regiment .</brief_summary>
	<brief_title>Long-term Trial Growth Hormone Deficiency Adults ( GHDA )</brief_title>
	<detailed_description />
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Subjects complete GHLiquid1518 . If subject history treatment tumor pituitary peripheral site , two year pass since completion surgery , radiotherapy treatment , recurrence underlying disease exclude . Appropriate replacement therapy administer 24 week treatment pituitary hormone deficiency . Subject history acromegaly . Subject diabetes mellitus . Subject suffer malignancy . Several medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>